ReviewMolecular & cellular oncology2026
The LNK adaptor protein: a dual regulator of proliferation and migration in solid tumors.
Review in Molecular & cellular oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a significant public health problem. Alterations in critical cellular responses, such as proliferation, survival, and migration, are hallmarks of cancer. Deregulation of the JAK/STAT, MAPK, and PI3K/AKT signaling pathways has been implicated in the development of most solid cancers; therefore, their strict control is a primary research focus. The LNK adaptor protein is a key negative regulator of these pathways in normal cells and in certain hematological malignancies, where it regulates the proliferation, migration, and inflammatory response of different cell types. However, the function of LNK in solid tumors is less clear. Recent evidence suggests that LNK inhibits proliferation and migration in some types of solid tumors but activates these same processes in others. In this review, we provide an overview of the essential functions of LNK in healthy tissues, compare these functions with LNK's reported activities in solid tumors, and discuss the potential mechanisms involved in the dual actions of the LNK protein.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.